Search results
Eli Lilly Rises As Study Shows Omvoh Successful in Treating Crohn's Disease
Investopedia· 16 hours agoThe company noted that this year it has submitted a supplemental Biologics License Application for...
Dexcom details plans for over-the-counter CGM as insulin pump firms seek Type 2 coverage
MedTech Dive via Yahoo Finance· 5 days agoDiabetes tech companies outlined their plans for upcoming products in first-quarter earnings calls ...
Washington Healthcare Update - May 2024 #3 | JD Supra
JD Supra· 23 hours agoThis Week in Washington: House appropriators release FY2025 topline appropriations levels; Senate Finance Committee releases white paper on Medicare...
Eli Lilly says its experimental weekly insulin works just as well as daily doses
Quartz· 5 days agoEli Lilly announced positive result on Thursday of its phase-3 clinical trails (QWINT-2 and QWINT-4)...
Is Novo Nordisk Stock a Millionaire Maker?
Motley Fool via Yahoo Finance· 4 days agoWhile they are initially approved for weight loss or diabetes, additional studies are showing their effectiveness in treating other issues as well....
FTC targets 300 Big Pharma 'junk patents,' sends warning letters to top drugmakers
BenefitsPRO· 6 days agoThe agency sent letters to 10 companies, warning that their patent listings were invalid. It also...
A pill could solve the Zepbound and Wegovy shortage, Eli Lilly executive says
Quartz· 7 days agoThe pharma giant is doing all it can to ramp up production of its highly-coveted diabetes and weight...
How Long Can I Stay on Ozempic For Weight Loss?
AOL· 5 days agoYou know Ozempic can help with weight loss, but how long can you stay on Ozempic exactly? Like snowflakes, music tastes and weird celebrity crushes, everyone’s weight loss ...
Weight loss pills, Ozempic's big fan, and Merck's skin cancer drug: Pharma news roundup
Quartz· 5 days agoIt may take a weight loss pill for Eli Lilly to finally meet demand for its popular anti-obesity...
Lilly's Once-Weekly Insulin Top-Line Results Show Benefit
Medscape· 6 days agoEli Lilly has announced positive phase 3 topline results for its once-weekly insulin efsitora alfa...
